Establishment of an immune monitoring for the prevention of rejection and infections after kidney transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032849

Enrollment

500

Registered

2023-10-12

Start date

2023-10-16

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z94.0

Interventions

Group 1: From already existing biomaterial (residual material) of the indicated diagnostics after kidney transplantation the Torque-Teno-Virus load in plasma and biopsy material in kidney transplanted

USA), a multiplex PCR containing primers for 202 different single nucleotide polymorphisms (SNPs), after extraction of cell-free DNA using the Circulating Nucleic Acid Kit (Qiagen, Redwood City, CA

USA). Investigation of novel biomarkers from existing biomaterial (residual material) should be performed from biomaterial at different time points, if available: (i) In the early post-transplant pe

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Kidney transplanted patients at the Heidelberg Kidney Center between 01.01.2017 and 31.12.2021

Exclusion criteria

Exclusion criteria: Failure to meet inclusion critera

Design outcomes

Primary

Measure	Time frame
Infections (CMV/BKV/EBV/bacterial infections/fungal infections) in the first 3 years after kidney transplantation.	—

Secondary

Measure	Time frame
Malignancy within 10 years after kidney transplantation	—

Countries

Germany

Contacts

Public ContactLouise Benning

Nierenzentrum Heidelberg

louise.benning@med.uni-heidelberg.de+49 6221 9112 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026